Indoco Remedies 

₹200.95
9
+₹3.85+1.95% 今天

統計

當日最高
202.19
當日最低
198.22
52週高點
349.8
52週低點
162.19
成交量
1,603
平均成交量
62,253
市值
18.54B
本益比
-
股息殖利率
0.1%
股息
0.2

即將到來

股息

0.1%股息殖利率
Sep 25
₹0.2
Sep 24
₹1.5
Sep 23
₹2.25
Sep 22
₹1.5
Sep 22
₹0.75
10年成長
-18.77%
5年成長
-33.17%
3年成長
-55.37%
1年成長
不適用

財報

26May預期
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
下一步
-4.43
-2.37
-0.3
1.76
預期EPS
-3.503080318465
實際EPS
不適用

財務

-4.49%利潤率
未盈利
2019
2020
2021
2022
2023
2024
32.83B營收
-1.47B淨利

其他人也在關注

此清單是根據在 Stock Events 上追蹤 INDOCO.NSE 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Indoco Remedies Limited manufactures and markets formulations and active pharmaceutical ingredients in India and internationally. It offers products for gastrointestinal, anti-infectives, respiratory, stomatological, vitamins/minerals/nutrients, urological, ophthal/ontological, dermatology, pain/analgesic, cardiac, anti-diabetic, and gynaecological therapeutic areas. The company also provides branded generics comprising analgesic tablets and topical preparations; anti-hypertensive; protein supplements; multivitamin tablets and syrups; antibiotic tablets, syrups, and injectables; oral rehydration powders; antacids; and antihistaminic, anti-inflammatory drugs, etc. In addition, it provides analytical services, such as impurity profile, particle size analysis, polymorphism and compatibility studies, heavy metal analysis, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and validation services. Further, the company offers architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering. Additionally, it provides contract research services, such as custom chemical synthesis of molecules and intermediates; process chemistry research and development; non-infringing process designing and scale up; and analytical method development, validation, impurity characterization, and polymorphic studies, solutions, as well as intellectual property management. The company was formerly known as Indo Continental Trading Company. Indoco Remedies Limited was founded in 1945 and is based in Mumbai, India.
Show more...
執行長
Mr. Suresh Govind Kare
員工
6000
國家
IN
ISIN
INE873D01024

上市

0 Comments

分享你的想法

FAQ

Indoco Remedies 今天的股價是多少?
INDOCO.NSE 目前價格為 ₹200.95 INR,過去 24 小時上漲了 +1.95%。在圖表上更密切關注 Indoco Remedies 股價表現。
Indoco Remedies 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Indoco Remedies 的股票以代號 INDOCO.NSE 進行交易。
Indoco Remedies 的股價在上漲嗎?
INDOCO.NSE 股票較上週上漲 +5.24%,本月上漲 +1.37%,但過去一年 Indoco Remedies 下跌 -12.17%。
Indoco Remedies 的市值是多少?
今天 Indoco Remedies 的市值為 18.54B
Indoco Remedies 下一次財報日期是什麼時候?
Indoco Remedies 將於 May 26, 2026 公布下一次財報。
Indoco Remedies 上一季度的財報如何?
INDOCO.NSE 上一季度的財報為每股 -3.22 INR,預估為 -2.57 INR,帶來 -25.49% 的驚喜。下一季度的預估財報為每股 不適用 INR。
Indoco Remedies 去年的營收是多少?
Indoco Remedies 去年的營收為 32.83BINR。
Indoco Remedies 去年的淨利是多少?
INDOCO.NSE 去年的淨收益為 -1.47BINR。
Indoco Remedies 會發放股息嗎?
是的,INDOCO.NSE 的股息每 年度 發放一次。每股最新股息為 0.2 INR。截至今日,股息殖利率(FWD)% 為 0.1%。
Indoco Remedies 有多少名員工?
截至 April 09, 2026,公司共有 6,000 名員工。
Indoco Remedies 位於哪個產業?
Indoco Remedies從事於Health Care產業。
Indoco Remedies 何時完成拆股?
Indoco Remedies 上次拆股發生於 May 17, 2012,比例為 5:1。
Indoco Remedies 的總部在哪裡?
Indoco Remedies 的總部位於 IN 的 Mumbai。